Results 1 to 10 of about 2,155 (206)

Scleral fixation of fluocinolone acetonide implant [PDF]

American Journal of Ophthalmology Case Reports, 2020
Purpose: To report on the technique of scleral fixation of fluocinolone acetonide (FAc) implant in 2 eyes with recalcitrant diabetic macular edema (DME). Observations: Two eyes of 2 patients with persistent DME, partially responsive to anti-VEGF therapy,
Homayoun Tabandeh
exaly   +6 more sources

Fluocinolone Acetonide Implant Removal From the Vitreous Cavity [PDF]

Journal of Vitreoretinal Diseases, 2023
Purpose: To describe a technique for fluocinolone acetonide implant removal from the vitreous cavity. Methods: A case report and review of surgical methods were performed. Results: The technique to remove a fluocinolone acetonide implant from the vitreous cavity was safe and effective. The vitreous cutter was used to align the implant coaxially with a
Nita Valikodath
exaly   +4 more sources

Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis [PDF]

Journal of Clinical Medicine, 2021
The efficacy of the 0.19-mg fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN) in the treatment of non-infectious uveitic macular edema (UME) was assessed on twenty-six patients (34 eyes) with non-infectious UME between 2013 and 2020, in a mean follow-up of 18 ± 19.3 (mean ± SD) months. Macular edema was resolved in 24 (70.6%) cases.
Gerd U Auffarth,, Febo, Lucy Joanne Kessler, Ramin Khoramnia   +2 more
exaly   +4 more sources

Migration of a fluocinolone acetonide implant (Yutiq) to the anterior chamber and its nonurgent removal [PDF]

American Journal of Ophthalmology Case Reports, 2020
Hamidah Mahmud, Jay M Stewart
exaly   +4 more sources

Intraocular Pressure Changes After Intravitreal Fluocinolone Acetonide Implant: Results from Four European Countries [PDF]

Ophthalmol Ther, 2022
Introduction: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant delivers a continuous intravitreal corticosteroid dose for the treatment of refractory diabetic macular oedema (DMO).
Arnould L., Baillif S., Barbosa-Breda J., Bourredjem A., Busch C., Creuzot-Garcher C., Gabrielle P. -H., Grise-Dulac A., Hamza M., Lebrize S., Lupidi M., Mariotti C., Massin P., Rehak M.   +13 more
core   +4 more sources

Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies [PDF]

Drug Des Devel Ther, 2023
Fluocinolone acetonide (FAc) intravitreal implant (Iluvien®) is a corticosteroid implant indicated for the treatment of diabetic macular oedema (DMO) in patients who have previously received conventional treatment without good response, non– infectious ...
Georgios D Panos, Lorenzo Motta, Maryam M Mushtaq, Matteo Ripa, Yusuf Mushtaq, Zisis Gatzioufas   +5 more
core   +2 more sources

Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience [PDF]

Scientific Reports, 2021
We conducted a meta-analysis of real-world studies on the 0.19 mg Fluocinolone Acetonide (FAc) intravitreal implant for chronic diabetic macular oedema (DMO), comparing these findings with the Fluocinolone Acetonide for Diabetic Macular Edema (FAME ...
Matteo Fallico, Andrea Maugeri, Andrew Lotery, Antonio Longo, Vincenza Bonfiglio, Andrea Russo, Teresio Avitabile, Claudio Furino, Gilda Cennamo, Martina Barchitta, Antonella Agodi, Paola Marolo, Luca Ventre, Paolo Caselgrandi, Michele Reibaldi   +14 more
doaj   +2 more sources

Clinical impact of the 0.2 µg/day fluocinolone acetonide intravitreal implant: outcomes from the ILUVIEN® clinical evidence study in Portugal

Therapeutic Advances in Ophthalmology, 2020
Introduction: The ILUVIEN ® (fluocinolone acetonide) Clinical Evidence in Portugal (ICE-PT) study is a retrospective, multicenter, observational study evaluating the effectiveness and safety of the FAc implant in patients with diabetic macular edema ...
Ângela M Carneiro, Angelina Meireles
exaly   +2 more sources

Radiation-induced maculopathy and fluocinolone acetonide implant [PDF]

Graefe's Archive for Clinical and Experimental Ophthalmology
Abstract Purpose This study evaluates the effectiveness of fluocinolone acetonide (FAc) implants in managing radiation maculopathy, a complication of ocular irradiation. The primary outcomes were the change in best-corrected visual acuity (BCVA) and central foveal thickness (CFT), and the impact on therapeutic burden ...
Jules Fricker, Sacha Nahon-Esteve, Sarah Tick, Maxime Nhari, Géraldine Chotard, Anh-Minh Nguyen, Stéphanie Baillif, Laurent Kodjikian, Thibaud Mathis   +8 more
openaire   +3 more sources

Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study [PDF]

Ophthalmology and Therapy, 2023
Introduction The aim of this study was to assess the efficacy and safety of fluocinolone acetonide implant (FAci) injected 1 month after the last dexamethasone intravitreal implant (DEXi) in chronic diabetic macular oedema (DME) patients.
Nicolas Rousseau, Olivier Lebreton, Hélène Masse, Yann Maucourant, Valentin Pipelart, Manon Clement, Marie-Laure Le Lez, Raoul Kanav Khanna, Maxime Pepin, Yannick Eude, Guylène Le Meur, Michel Weber, Jean-Baptiste Ducloyer   +12 more
doaj   +2 more sources